06/12/2024 4:32 PM | ROBIN SHERRINGTON (Reporting) Xenon Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024 4:42 PM | GANNON STEVEN (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 4:42 PM | GAROFALO ELIZABETH A. (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 4:42 PM | Gover Justin D. (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 4:42 PM | Machado Patrick (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 4:43 PM | PATOU GARY (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 4:41 PM | Svoronos Dawn (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
06/05/2024 4:41 PM | Cannon Gillian (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 4:30 PM | PIMSTONE SIMON N. (Reporting) Xenon Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024 3:22 PM | Xenon Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/05/2024 3:12 PM | Xenon Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 3:09 PM | Xenon Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/26/2024 3:26 PM | Xenon Pharmaceuticals (Filer)
| Form DEF 14A | |
04/19/2024 3:21 PM | Xenon Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/12/2024 5:41 PM | AULIN SHERRY (Reporting) Xenon Pharmaceuticals (Issuer) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 5:42 PM | Von Seggern Christopher (Reporting) Xenon Pharmaceuticals (Issuer) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 5:33 PM | MORTIMER IAN (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 5:34 PM | DiFabio Andrea (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 5:35 PM | ROBIN SHERRINGTON (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 5:37 PM | EMPFIELD JAMES R. (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 5:38 PM | KENNEY CHRISTOPHER JOHN (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:09 PM | GAROFALO ELIZABETH A. (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 5:47 PM | GAROFALO ELIZABETH A. (Reporting) Xenon Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024 4:27 PM | Xenon Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/08/2024 4:28 PM | GANNON STEVEN (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:31 PM | ROBIN SHERRINGTON (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 6:03 PM | GANNON STEVEN (Reporting) Xenon Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024 6:04 PM | ROBIN SHERRINGTON (Reporting) Xenon Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 3:36 PM | Xenon Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/29/2024 3:10 PM | Xenon Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 8:12 AM | Avoro Capital Advisors LLC (Filed by) Xenon Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024 6:43 AM | DRIEHAUS CAPITAL MANAGEMENT LLC (Filed by) Xenon Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024 9:05 AM | FMR LLC (Filed by) Xenon Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/02/2024 3:41 PM | ROBIN SHERRINGTON (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 4:04 PM | AZAB MOHAMMAD (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2023 8:50 PM | PATOU GARY (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4/A | |
12/15/2023 4:38 PM | PATOU GARY (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2023 7:02 PM | PATOU GARY (Reporting) Xenon Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023 4:05 PM | Xenon Pharmaceuticals (Filer)
| Form 424B5 | |
11/27/2023 6:03 AM | Xenon Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/24/2023 3:27 PM | Svoronos Dawn (Reporting) Xenon Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
New way to “hijack” stocks (Ad) We may have just found a unique way to “hijack” the stock market…
No, it’s not a matter of picking the next Amazon or guessing on the next A.I. moonshot like NVDA…
Options expert, Nate Tucci, claims as long as you deploy a certain type of trade before the end of the week anyone could have a shot to target right around $1,250 in a matter of days (based on $2.5k invested)
But that’s not even the best part…
Unlike most methods, you don’t need to even know WHEN to exit this trade… Click here to catch the next Automated Option |
08/24/2023 3:33 PM | Svoronos Dawn (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/10/2023 5:40 PM | Cannon Gillian (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/10/2023 5:56 PM | Cannon Gillian (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/10/2023 6:00 PM | Gover Justin D. (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/10/2023 6:05 PM | Gover Justin D. (Reporting) Xenon Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |